← Open Payments lookup

NICHOLAS TINDONG: Open Payments

NPI 1386637098 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,744 in 51 payments from 11 companies in 2025. Trend: 2023 $213 · 2024 $599 · 2025 $1,744

Food & beverage: $1,744
CompanyPaymentsAmount
ABBVIE INC.7$344
Otsuka America Pharmaceutical, Inc.4$279
Alkermes, Inc.11$238
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$196
Neurocrine BioSciences, Inc.3$191
Axsome Therapeutics, Inc.4$182
Lundbeck LLC7$161
Janssen Pharmaceuticals, Inc2$64
Teva Pharmaceuticals USA, Inc.2$34
E.R. Squibb & Sons, L.L.C.1$28

Products named: ABILIFY MAINTENA, VRAYLAR, ARISTADA, CAPLYTA, INGREZZA, Auvelity, REXULTI, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.